Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich

01:47 EDT 30 Apr 2018 | NEJM

More From BioPortfolio on "Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich"